Pacific Biosciences of California, Inc. (PACB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
| Previous close | 1.9900 |
| Open | 2.0100 |
| Bid | 1.9400 x 4800 |
| Ask | 1.9900 x 4800 |
| Day's range | 1.9101 - 2.0400 |
| 52-week range | 1.2500 - 14.5500 |
| Volume | |
| Avg. volume | 10,435,247 |
| Market cap | 535.154M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2100 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.08 |
ZacksInvestors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
Pacific Biosciences (PACB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ZacksHere's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks
Pacific Biosciences (PACB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ZacksPacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
© 2024 Yahoo. All rights reserved.